Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
Condition: Staphylococcus Aureus Bacteremia Interventions: Drug: Ceftobiprole medocaril; Drug: Daptomycin Sponsors: Basilea Pharmaceutica; Department of Health and Human Services Not yet recruiting - verified April 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cubicin | Staphylococcus Aureus